Inventiva cuts pipeline, lays off nearly entire research team in bid to get to Phase 3 MASH readout

Inventiva is trimming its pipeline and enacting layoffs in an effort to get its lead MASH drug approved, the company announced Monday afternoon. The plan will center around its MASH candidate ...